BEKhealth Secures $4M to Revolutionize Patient Matching in Clinical Trials

We are thrilled to announce a transformative milestone for BEKhealth as we successfully raise $4,000,000 in our latest funding round.

This significant investment marks an exciting new chapter for our company, purpose-built for organizations conducting clinical trials and observational studies.

At BEKhealth, our mission is clear: empower clinical trial sites to secure the right patient for the right research at the right time through our innovative, AI-powered patient-matching platform.

By leveraging cutting-edge technology and deep clinical expertise, we optimize feasibility and accelerate patient identification, extracting structured and unstructured data from electronic medical records (EMRs) with astonishing precision—capturing three times more trial criteria than traditional methods.

The funds raised will be strategically deployed to further enhance our software platform and augment our data extraction capabilities, ensuring that our customers can rely on the most accurate and efficient process for matching eligible candidates to clinical trials.

This will allow site teams to concentrate on the intricacies of research and patient care, facilitating a more streamlined and effective approach to clinical trial operations.

Additionally, investments will be made toward scaling our clinical expert support, expanding the platform’s integration capabilities, and continuously improving the robustness of our AI-driven analytics.

At BEKhealth, we are dedicated to redefining how clinical trials are conducted by equipping sites with state-of-the-art technology that mitigates common challenges in patient recruitment.

This funding is not only a vote of confidence in our innovative approach, but also a vital step towards making clinical trial participation more accessible and efficient for patients and researchers alike.

We extend our sincere gratitude to our investors and partners as we steer towards a future of improved clinical outcomes and accelerated medical breakthroughs.